why choose us

First received: November 23, 2022

Clinical Trial: Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Acute Infectious Keratoconjunctivitis

Study Type: INTERVENTIONAL


Official Title: Phase 2, Multicenter, Randomized, Double-Masked, Vehicle-Controlled Study of INV-102 Ophthalmic Solution in Patients With Acute Infectious Keratoconjunctivitis

Brief Summary: Phase 2, randomized study to assess topically administered eyedrops of INV-102 compared to vehicle during 1-week dosing in participants with Acute Infectious Keratoconjunctivitis (AIK).Participants will return for a follow up visit 1 week after end of treatment.

Read more